The full text of this article
Open innovation strategies in the UK biopharmaceutical sector
by Călin Gurău; Frank Lasch
International Journal of Entrepreneurial Venturing (IJEV), Vol. 3, No. 4, 2011
Abstract: In the last ten years, the paradigm of open innovation has modified the way in which the research and development process is organised and managed by high-technology firms. However, this model should be adapted to the specific characteristics and conditions of each industrial sector. Using the data collected through interviews with 23 managers of UK biopharmaceutical SMEs, this study attempts to identify the factors that may enhance the capacity of these firms to develop and manage open innovation systems. Findings indicate that the size of the firm, its organisational stage, its capability to develop partnerships and its capacity to identify partner organisations with complementary resources influence the capacity of the biopharmaceutical organisation to implement and manage open innovation systems.
Online publication date: Wed, 26-Oct-2011
is only available to individual subscribers or to users at subscribing institutions.
Go to Inderscience Online Journals to access the Full Text of this article.
Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.
Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Entrepreneurial Venturing (IJEV):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable).
See our Orders page to subscribe.
If you still need assistance, please email firstname.lastname@example.org